The effects of the English libel laws on medicine and research - a personal view
Dr Peter Wilmshurst is a consultant cardiologist. He is a leader in his field, and also a whistleblower, drawing attention to that which he believes to be wrong. He was presented with the HealthWatch Award 2003. Peter Wilmshurst has clashed with universities, editors, the medical establishment, and - perhaps inevitably - with the pharmaceutical industry. It is this last encounter that has taken him to court and that has made explicit and very public the relevance of the UK's libel laws to scientific research.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 29 (2011)
Issue (Month): 1 ()
|Contact details of provider:|| Web page: http://www.tandfonline.com/CPRO20|
|Order Information:||Web: http://www.tandfonline.com/pricing/journal/CPRO20|
When requesting a correction, please mention this item's handle: RePEc:taf:promet:v:29:y:2011:i:1:p:67-71. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Chris Longhurst)
If references are entirely missing, you can add them using this form.